These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 8862265

  • 21. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN, Ebenezer G, Rao GS, Natrajan MM, Balasundaram B.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [Abstract] [Full Text] [Related]

  • 22. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N, Snehalatha S, Lobo D, Aschhoff M, Job CK.
    Indian J Lepr; 1995 Sep; 67(4):427-33. PubMed ID: 8849919
    [Abstract] [Full Text] [Related]

  • 23. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A, Hari L, Nagarajan M, Prabhakar R.
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [Abstract] [Full Text] [Related]

  • 24. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK, Arora PN, Ramasastry CV, Dhaka RS.
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [Abstract] [Full Text] [Related]

  • 25. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G, Pönnighaus JM, Fine PE, Wilson RJ.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
    [Abstract] [Full Text] [Related]

  • 26. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK, Cherian A.
    Indian J Lepr; 1991 Jun; 63(1):61-9. PubMed ID: 1919091
    [Abstract] [Full Text] [Related]

  • 27. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
    Revankar CR, Karjivkar VG, Gurav VJ, Ganapati R.
    Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
    [Abstract] [Full Text] [Related]

  • 28. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [Abstract] [Full Text] [Related]

  • 29. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

  • 30. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A, Nadkarni NJ, Kini MS, Mehta VR.
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [Abstract] [Full Text] [Related]

  • 31. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT.
    Vaccine; 2004 Sep 09; 22(27-28):3649-57. PubMed ID: 15315844
    [Abstract] [Full Text] [Related]

  • 32. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1992 Sep 09; 60(3):436-44. PubMed ID: 1474282
    [Abstract] [Full Text] [Related]

  • 33. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS, Bhanage ND, Sawant KV, Ganapati R.
    Indian J Lepr; 1988 Jul 09; 60(3):393-9. PubMed ID: 3058827
    [Abstract] [Full Text] [Related]

  • 34. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA, Mearag I, Saleh NM, Saied A.
    J Egypt Soc Parasitol; 2009 Dec 09; 39(3):933-42. PubMed ID: 20120756
    [Abstract] [Full Text] [Related]

  • 35. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S, Somasiri KG, Chularatna W.
    Ceylon Med J; 1993 Dec 09; 38(4):174-7. PubMed ID: 8143332
    [Abstract] [Full Text] [Related]

  • 36. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY, Yu XL, Zhang MS, Duan CX, Huang WB, Zhang SB, Zhu K, Ma JF.
    Int J Lepr Other Mycobact Dis; 1989 Sep 09; 57(3):622-7. PubMed ID: 2778368
    [Abstract] [Full Text] [Related]

  • 37. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A, Balakrishnan A, Nagarajan M, Prabhakar R, Tripathy SP, Christian M, Somasundaram PR.
    Int J Lepr Other Mycobact Dis; 1990 Jun 09; 58(2):273-80. PubMed ID: 2198314
    [Abstract] [Full Text] [Related]

  • 38. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V, Rao MK.
    Indian J Lepr; 1989 Jan 09; 61(1):31-43. PubMed ID: 2784822
    [Abstract] [Full Text] [Related]

  • 39. Histopathological study of apparently normal skin of patients with leprosy.
    El-Darouti MA, Hussein S, Marzouk SA, Nabil N, Hunter NS, Mahgoub D, El-Eishi NH, Abdel-Halim MR.
    Int J Dermatol; 2006 Mar 09; 45(3):292-6. PubMed ID: 16533232
    [Abstract] [Full Text] [Related]

  • 40. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun 09; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.